| Company Name | Fiscal Year | EPS (Actual) | EPS (Estimated) | Revenue (Actual) | Revenue (Estimated) | Exchange | |||
|---|---|---|---|---|---|---|---|---|---|
| Loading past events... | |||||||||
|
Monday - Nov 25, 2019 |
|||||||||
| - | $0.49 | $0.46 | $7.22B | $6.77B |
NYSE |
||||
| Q4 FY19 | $1.48 | $1.32 | $3.39B | $3.03B |
NYSE |
||||
|
PVH
PVH
|
- | $3.10 | $3.00 | $2.59B | $2.50B |
NYSE |
|||
|
Beacon Roofing Supply
BECN
|
Q4 FY19 | $1.04 | $1.17 | $2.03B | $2.36B |
NASDAQ |
|||
| - | $0.89 | $0.86 | $1.37B | $1.73B |
NYSE |
||||
Caleres
CAL
|
Q3 FY19 | $0.78 | $0.83 | $792.38M | $843.17M |
NYSE |
|||
| Q1 FY20 | $0.17 | $0.17 | $771.90M | $757.20M |
NASDAQ |
||||
| Q1 FY20 | -$0.71 | -$0.75 | $314.77M | $332.50M |
NASDAQ |
||||
|
Spire
SR
|
- | -$0.54 | -$0.52 | $225.60M | $217.24M |
NYSE |
|||
|
ReneSola Ltd
SOL
|
Q3 FY19 | $0.17 | $0.05 | $65.96M | $70.37M |
NYSE |
|||
|
Arrowhead Pharmaceuticals
ARWR
|
- | $0.11 | $0.16 | $43.29M | $62.97M |
NASDAQ |
|||
|
Golub Capital BDC
GBDC
|
- | $0.35 | $0.32 | $48.98M | $48.98M |
NASDAQ |
|||
|
Ambarella
AMBA
|
Q3 FY20 | $0.32 | $0.21 | $67.92M | $44.57M |
NASDAQ |
|||
|
SiTime
SITM
|
- | -$0.38 | - | $15.84M | - |
NASDAQ |
|||
|
Alpine Income Property Trust
PINE
|
- | $0.12 | - | $3.09M | - |
NYSE |
|||
|
Phathom Pharmaceuticals
PHAT
|
- | -$9.30 | -$1.14 | - | - |
NASDAQ |
|||
|
Artelo Biosciences
ARTL
|
- | -$37.77 | -$0.51 | - | - |
NASDAQ |
|||
| Show 7 more companies | |||||||||
